These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28742405)

  • 1. True Dopers or Negligent Athletes? An Analysis of Anti-Doping Rule Violations Reported to the World Anti-Doping Agency 2010-2012.
    de Hon O; van Bottenburg M
    Subst Use Misuse; 2017 Dec; 52(14):1932-1936. PubMed ID: 28742405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-doping policy development process in the sports world (1968~1999): focusing on IOC activities and passive response from Korea].
    Hwang ER; Kim TY
    Uisahak; 2014 Aug; 23(2):269-318. PubMed ID: 25223222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current situation and measures to promote anti-doping activities in Japan].
    Asakawa S
    Yakugaku Zasshi; 2011; 131(12):1755-6. PubMed ID: 22129872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doping control, providing whereabouts and the importance of privacy for elite athletes.
    Valkenburg D; de Hon O; van Hilvoorde I
    Int J Drug Policy; 2014 Mar; 25(2):212-8. PubMed ID: 24462318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The World Anti-Doping Code 2003--consequences for physicians associated with elite athletes.
    Striegel H; Rössner D; Simon P; Niess AM
    Int J Sports Med; 2005 Apr; 26(3):238-43. PubMed ID: 15776342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Australian athletes' knowledge of the WADA Prohibited Substances List and performance enhancing substances.
    Orr R; Grassmayr M; Macniven R; Grunseit A; Halaki M; Bauman A
    Int J Drug Policy; 2018 Jun; 56():40-45. PubMed ID: 29550541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Between medical treatment and performance enhancement: an investigation of how elite athletes experience Therapeutic Use Exemptions.
    Overbye M; Wagner U
    Int J Drug Policy; 2013 Nov; 24(6):579-88. PubMed ID: 23582632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication use in athletes selected for doping control at the Sydney Olympics (2000).
    Corrigan B; Kazlauskas R
    Clin J Sport Med; 2003 Jan; 13(1):33-40. PubMed ID: 12544162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Medicolegal aspects of doping in sports].
    Pruvost J; Depiesse F
    Ann Readapt Med Phys; 2004 Aug; 47(6):263-73. PubMed ID: 15297116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Athlete Biological Passport: an integral element of innovative strategies in antidoping.
    Vernec AR
    Br J Sports Med; 2014 May; 48(10):817-9. PubMed ID: 24659508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of anti-doping education and doping control experience on anti-doping knowledge in Japanese university athletes: a cross-sectional study.
    Murofushi Y; Kawata Y; Kamimura A; Hirosawa M; Shibata N
    Subst Abuse Treat Prev Policy; 2018 Dec; 13(1):44. PubMed ID: 30518383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doping knowledge, attitudes, and practices of Ugandan athletes': a cross-sectional study.
    Muwonge H; Zavuga R; Kabenge PA
    Subst Abuse Treat Prev Policy; 2015 Sep; 10():37. PubMed ID: 26395767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Korean national athletes' knowledge, practices, and attitudes of doping: a cross-sectional study.
    Kim T; Kim YH
    Subst Abuse Treat Prev Policy; 2017 Feb; 12(1):7. PubMed ID: 28196542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doping in sport: an analysis of sanctioned UK rugby union players between 2009 and 2015.
    Whitaker L; Backhouse S
    J Sports Sci; 2017 Aug; 35(16):1607-1613. PubMed ID: 27578446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Factors Associated with Potential Doping Behavior in Sports: A Cross-Sectional Analysis in High-Level Competitive Swimmers.
    Devcic S; Bednarik J; Maric D; Versic S; Sekulic D; Kutlesa Z; Bianco A; Rodek J; Liposek S
    Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30103461
    [No Abstract]   [Full Text] [Related]  

  • 16. A forensic perspective of the AFL investigation into peptides: an antidoping investigation case study.
    Harcourt PR; Marclay F; Clothier B
    Br J Sports Med; 2014 May; 48(10):810-3. PubMed ID: 24642697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doping in the Ultimate Fighting Championship (UFC): A 4-year epidemiological analysis.
    Fares MY; Baydoun H; Salhab HA; Khachfe HH; Fares Y; Fares J; Abboud JA
    Drug Test Anal; 2021 Apr; 13(4):785-793. PubMed ID: 33270353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating the elite athlete: anti-doping information for the health professional.
    Tandon S; Bowers LD; Fedoruk MN
    Mo Med; 2015; 112(2):122-8. PubMed ID: 25958657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential analysis of the doping behaviour templates in three types of sports.
    Rodek J; Idrizović K; Zenić N; Perasović B; Kondric M
    Coll Antropol; 2013 May; 37 Suppl 2():211-7. PubMed ID: 23914509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Not Available].
    Bieri A; Kamber M; Sterchi M; Mullis PE
    Ther Umsch; 2014 Apr; 71(4):245-52. PubMed ID: 24670606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.